For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels.
“This is a very effective drug that we should be using to treat breast cancer, but the problem is that it causes high blood sugar, which also can decrease the efficacy of the medication,” explained study co-author Dr. Neil Iyengar. He is a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City.
Source: USNEWS
